{"database": "openregs", "table": "documents", "rows": [["FDA-2016-N-1111-1711", "FDA", "FDA-2016-N-1111", "Attachment 8 Product Description of Antabuse Disulfran Tablet re: Supplemental Comment from Eckert Seamans Judge Rotenberg Educational Center, Inc.", "Supporting & Related Material", "Background Material", "2017-04-11T04:00:00Z", 2017, 4, null, null, "2017-04-11T14:12:15Z", null, 0, 0, "090000648254a538"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-N-1111-1711"], "units": {}, "query_ms": 31.2580430181697, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}